[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-346313-105":59,"doc-detail-346313-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","ferroptosis-related-gene-signature-predicts-prognosis-and-immunotherapy-response-in-hepatocellular-carcinoma-a-multi-cohort-retrospective-study","Ferroptosis-related gene signature predicts prognosis and immunotherapy response in hepatocellular carcinoma - A multi-cohort retrospective study","","Hepatocellular carcinoma (HCC) shows high incidence and mortality worldwide, and ferroptosis in the tumor microenvironment is an important but incompletely characterized process. Using ferroptosis-related gene (FRG) expression and clinical data from The Cancer Genome Atlas, two ferroptosis-related molecular subtypes were defined and compared. Cox regression and LASSO modeling produced an FRG-based signature to predict overall survival and potential immunotherapy benefits. Key FRGs were validated in clinical specimens by qRT-PCR and immunohistochemistry, with differences in mutations, immune activity, and outcomes across subtypes.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/ferroptosis-related-gene-signature-predicts-prognosis-and-immunotherapy-response-in-hepatocellular-carcinoma-a-multi-cohort-retrospective-study/346313/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/ferroptosis-related-gene-signature-predicts-prognosis-and-immunotherapy-response-in-hepatocellular-carcinoma-a-multi-cohort-retrospective-study/346313.png","ImageObject",300,407,{"name":92,"@type":93},"Himbo","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-10","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How were ferroptosis-related genes used to predict prognosis in HCC?","Question",{"text":112,"@type":113},"FRG expression and clinical data from TCGA were analyzed, and Cox regression with LASSO modeling produced a predictive model for overall survival in hepatocellular carcinoma patients.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What validated the key ferroptosis-related genes?",{"text":117,"@type":113},"Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) and immunohistochemistry (IHC) were performed on clinical HCC specimens to validate the key FRGs.",{"name":119,"@type":110,"acceptedAnswer":120},"How does the FRG signature relate to immunotherapy response?",{"text":121,"@type":113},"The study assessed immunotherapy benefit by evaluating the predicted outcomes from the FRG-based model, indicating different potential benefits across risk groups and ferroptosis-related subtypes.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},346313,1790830847,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687197100911,"https://ap-avatar.wpscdn.com/avatar/a000239b6f1da00475?x-image-process=image/resize,m_fixed,w_180,h_180&k=1785132997149421697","®  \n Observational Study   \nFerroptosis-related gene signature predicts prognosis and immunotherapy response in hepatocellular carcinoma  \nA multi-cohort retrospective study  \nLipeng Li, MDa ,b , Jinshu Pang, MDa , Jiamin Chen, MDa , Yunjing Pan, MMa , Li Liang, MDa ,b , Xiumei Bai, MDa , Yun He, MDa , Hong Yang, MDa ,*  \n\n| Abstract\u003Cbr>Hepatocellular carcinoma (HCC), characterized by elevated incidence and mortality rates, has a considerable economic impact worldwide. The function of ferroptosis within the tumor microenvironment of HCC is crucial, and the specific contributions offerroptosis-related genes (FRGs) are yet to be fully explored. FRG expression levels and relevant clinical data were sourced from The Cancer Genome Atlas. Two distinct ferroptosis-related subtypes were identified in liver cancer and their interrelationships were comprehensively examined. Using Cox regression and least absolute shrinkage and selection operator regression analysis, we created a predictive model based on FRGs to forecast overall survival and assess the potential benefits of immunotherapy inpatients with HCC. Quantitative reverse transcription-polymerase chain reaction and IHC assays were conducted on clinical HCC specimens to validate the key FRGs. Significant differences in gene mutations, immune reactions, and prognostic outcomes were observed between the 2 distinct ferroptosis-related subtypes. An eight-gene signature consisting of SLC1A5, KIF20A, SLC7A11, CARS1, MYCN, PRDX6, GPX4, and KLF2 was established as a predictive model for liver cancer and was validated against data from GSE76427 and the International Cancer Genome Consortium cohorts. According to the FRG model, individuals classified as low-risk exhibited more favorable survival prospects compared to their high-risk counterparts (P \u003C .05) . Overall, our investigation highlights the promise of FRGs as prognostic biomarkers and immunotherapy response in HCC, providing a novel approach for personalized patient management. |\n| --- |\n| Abbreviations: AR = androgen receptor, FDR = false discovery rate, FRDEGs = ferroptosis-related differentially expressed genes, FRGs = ferroptosis-related genes, GSVA = gene set variation analysis, HCC = hepatocellular carcinoma, ICB = immune checkpoint blockade, ICGC = International Cancer Genome Consortium, IHC = immunohistochemistry, IPS = immunophenoscores, LASSO = least absolute shrinkage and selection operator, LIHC = liver hepatocellular carcinoma, MSI = microsatellite instability, OS = overall survival, PD-1 = programmed cell death protein 1, PPI = protein–protein interaction, qRT-PCR = quantitative reverse transcription-polymerase chain reaction, ROC = receiver operating characteristic, TCGA = The Cancer Genome Atlas, TIDE = tumor immune dysfunction and exclusion, TMB = tumor mutation burden, TME = tumor microenvironment, TPIM = tumorpromoting immune macrophages. |\n| Keywords: ferroptosis, hepatocellular carcinoma, immunotherapy, prognosis, risk score |\n\n1. Introduction  \nHepatocellular carcinoma (HCC) is the predominant typeof primary liver cancer and ranks third in terms of cancerrelated mortality globally, claiming the lives of 7.6 million  \npeople in 2022.[1] Projections suggest that by the year 2040, the incidence and mortality of liver cancer will exceed a 55% increase. [2] Curative interventions for HCC, such as surgical resection and liver transplantation, are primarily applicable  \nThis study was funded by the Joint Project on Regional High-Incidence Diseases Research of Guangxi Natural Science Foundation (2024GXNSFBA010038), the National Natural Science Foundation of China (82460350) and the China Postdoctoral Science Foundation (2023MD744191).  \nThe authors have no conflicts of interest to disclose.  \nAll data generated or analyzed during this study are included in this published article [and its supplementary information files].  \nThe research including clinical samples received ethical approval from the Ethics Committee of th","cbCaibRRY9wR580g","https://ap.wps.com/l/cbCaibRRY9wR580g","pdf",7762605,17,"English","# Abstract\n# Abbreviations\n# Introduction","[{\"question\":\"How were ferroptosis-related genes used to predict prognosis in HCC?\",\"answer\":\"FRG expression and clinical data from TCGA were analyzed, and Cox regression with LASSO modeling produced a predictive model for overall survival in hepatocellular carcinoma patients.\"},{\"question\":\"What validated the key ferroptosis-related genes?\",\"answer\":\"Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) and immunohistochemistry (IHC) were performed on clinical HCC specimens to validate the key FRGs.\"},{\"question\":\"How does the FRG signature relate to immunotherapy response?\",\"answer\":\"The study assessed immunotherapy benefit by evaluating the predicted outcomes from the FRG-based model, indicating different potential benefits across risk groups and ferroptosis-related subtypes.\"}]","Ferroptosis-related gene signature predicts prognosis and immunotherapy response in hepatocellular carcinoma - A multi-cohort retrospective study | PDF",1790060891,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c6d36ed78bfbb3a53deda4431d324507.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b0d5794751d4111f41ca7eb4bedd9e38.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2b31fd5a8742e483537b74319c95ec87.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9ca0af2923ef6729c48ef938f08c5417.webp",980,1306]